Temporal bone squamous cell carcinoma (TBSCC) is rare and often confers a poor prognosis. The aim of this study was to synthesize survival and recurrence outcomes data reported in the literature for patients who underwent temporal bone resection (TBR) for curative management of TBSCC. We considered TBSCC listed as originating from multiple subsites, including the external ear, parotid, and external auditory canal (EAC), or nonspecifically from the temporal bone.
Data Sources
PubMed, Cochrane Library, Embase, and manual search of bibliographies.
Review Method
A systematic literature review conducted in December 2020 according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.
Results
Survival data were collected from 51 retrospective studies, resulting in a pooled cohort of 501 patients with TBSCC. Compared to patients undergoing lateral TBR (LTBR), patients undergoing subtotal (SBTR) or total (TTBR) TBR exhibited significantly higher rates of stage IV disease (P < .001), positive surgical margins (P < .001), facial nerve involvement (P < .001), and recurrent disease (P < .001). A meta-analysis of 15 studies revealed a statistically significant 97% increase in mortality in patients who underwent STBR or TTBR. On multivariate analysis, recurrent disease was independently associated with worse overall survival (P < .001). On univariate analysis, facial nerve involvement was also associated with decreased overall survival (P < .001).
Conclusion
Recurrent disease was associated with risk of death in patients undergoing TBR. Larger prospective multi-institutional studies are needed to ascertain prognostic factors for a wider array of postoperative outcomes, including histology-specific survival and recurrence outcomes.
MoodySAHirschBEMyersEN. Squamous cell carcinoma of the external auditory canal: an evaluation of a staging system. Am J Otol. 2000;21:582-588.
2.
GidleyPWDeMonteF. Temporal bone malignancies. Neurosurg Clin North Am. 2013;24:97-110.
3.
AcharyaPPSarmaDMcKinnonB. Trends of temporal bone cancer: SEER database. Am J Otolaryngol. 2020;41:102297.
4.
SpectorJG. Management of temporal bone carcinomas: a therapeutic analysis of two groups of patients and long-term followup. Otolaryngol Head Neck Surg. 1991;104:58-66.
5.
LionelloMStritoniPFaccioloMC, et al. Temporal bone carcinoma: current diagnostic, therapeutic, and prognostic concepts. J Surg Oncol. 2014;110:383-392.
6.
GidleyPWThompsonCRRobertsDBDeMonteFHannaEY. The oncology of otology. Laryngoscope. 2012;122:393-400.
7.
da SilvaAPBredaEMonteiroE. Malignant tumors of the temporal bone—our experience. Braz J Otorhinolaryngol. 2016;82:479-483.
8.
ManolidisSPappasDJrVon DoerstenPJacksonCGGlasscockMEIII. Temporal bone and lateral skull base malignancy: experience and results with 81 patients. Am J Otol. 1998;19:S1-15.
9.
WierzbickaMKopećTSzyfterWBuczkowskaABoruckiŁ. Efficacy of petrosectomy in malignant invasion of the temporal bone. Br J Oral Maxillofac Surg. 2016;54:778-783.
10.
NyropMGrøntvedA. Cancer of the external auditory canal. Arch Otolaryngol Head Neck Surg. 2002;128:834-837.
11.
KimCSSuhMW. Skull base surgery for removal of temporal bone tumors. Acta Otolaryngol Suppl. 2007;558:4-14.
12.
AslıerMDoğanEİkizASarıoğluSAkmanFGüneriEA. Evaluation of lateral temporal bone resection in locally advanced tumours of the parotid gland. Indian J Otolaryngol Head Neck Surg. 2019;71:1402-1407.
13.
ChangCHShuMTLeeJCLeuYSChenYCLeeKS. Treatments and outcomes of malignant tumors of external auditory canal. Am J Otolaryngol. 2009;30:44-48.
14.
IsipraditPWadwongthamWAeumjaturapatSAramwatanapongP. Carcinoma of the external auditory canal. J Med Assoc Thailand. 2005;88:114-117.
15.
GaudetJEWalvekarRRArriagaMA, et al. Applicability of the Pittsburgh staging system for advanced cutaneous malignancy of the temporal bone. Skull Base. 2010;20:409-414.
16.
HoshikawaHMiyashitaTMoriN. Surgical procedures for external auditory canal carcinoma and the preservation of postoperative hearing. Case Rep Surg. 2012;2012:841372.
17.
SelesnickSHBurtBM. Regional spread of nonneurogenic tumors to the skull base via the facial nerve. Otol Neurotol. 2003;24:326-333.
18.
ParkJMKongJSChangKH, et al. The clinical characteristics and surgical outcomes of carcinoma of the external auditory canal: a multicenter study. J Int Adv Otol. 2018;14:278-284.
19.
Martinez-DevesaPBarnesMLMilfordCA. Malignant tumors of the ear and temporal bone: a study of 27 patients and review of their management. Skull Base. 2008;18:1-8.
20.
ZhangTDaiCWangZ. The misdiagnosis of external auditory canal carcinoma. Eur Arch Otorhinolaryngol. 2013;270:1607-1613.
21.
LeonettiJPSmithPGAnandVKKletzkerGRHartmanJM. Subtotal petrosectomy in the management of advanced parotid neoplasms. Otolaryngol Head Neck Surg. 1993;108:270-276.
22.
SeligmanKLSunDQTen EyckPPSchularickNMHansenMR. Temporal bone carcinoma: treatment patterns and survival. Laryngoscope. 2020;130:E11-E20.
23.
MatobaTHanaiNSuzukiH, et al. Treatment and outcomes of carcinoma of the external and middle ear: the validity of en bloc resection for advanced tumor. Neurol Med Chir (Tokyo). 2018;58:32-38.
24.
LiberatiAAltmanDGTetzlaffJ, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
25.
SlimKNiniEForestierDKwiatkowskiFPanisYChipponiJ. Methodological Index for Non-Randomized Studies (MINORS): development and validation of a new instrument. ANZ J Surg. 2003;73:712-716.
26.
ArriagaMCurtinHTakahashiHHirschBEKamererDB. Staging proposal for external auditory meatus carcinoma based on preoperative clinical examination and computed tomography findings. Ann Otol Rhinol Laryngol. 1990;99:714-721.
27.
AustinJRStewartKLFawziN. Squamous cell carcinoma of the external auditory canal: therapeutic prognosis based on a proposed staging system. Arch Otolaryngol Head Neck Surg. 1994;120:1228-1232.
28.
LangmanAYaringtonTPattersonSD. Malignant melanoma of the external auditory canal. Otolaryngol Head Neck Surg. 1996;114:645-648.
29.
MilbrathMMCampbellBHMadiedoGJanjanNA. Malignant melanoma of the external auditory canal. Am J Clin Oncol. 1998;21:28-30.
30.
GillespieMBFrancisHWCheeNEiseleDW. Squamous cell carcinoma of the temporal bone: a radiographic-pathologic correlation. Arch Otolaryngol Head Neck Surg. 2001;127:803-807.
31.
MagliuloGFusconiMPuliceG. Mucoepidermoid carcinoma of the external auditory canal: case report. Am J Otolaryngol. 2003;24:274-277.
32.
MoffatDAWagstaffSAHardyDG. The outcome of radical surgery and postoperative radiotherapy for squamous carcinoma of the temporal bone. Laryngoscope. 2005;115:341-347.
33.
BibasAGGleesonMJ. Bilateral squamous cell carcinoma of the temporal bones. Skull Base. 2006;16:213-218.
34.
NakagawaTKumamotoYNatoriY, et al. Squamous cell carcinoma of the external auditory canal and middle ear: an operation combined with preoperative chemoradiotherapy and a free surgical margin. Otol Neurotol. 2006;27:242-249.
35.
SelcukADereHBaharSSarikayaYOzcanM. Adenoid cystic carcinoma of the parotid gland presenting as temporal bone neoplasm: a case report. B-ENT. 2007;3:153-156.
36.
BibasAGWardVGleesonMJ. Squamous cell carcinoma of the temporal bone. J Laryngol Otol. 2008;122:1156-1161.
37.
DongFGidleyPWHoTLunaMAGinsbergLESturgisEM. Adenoid cystic carcinoma of the external auditory canal. Laryngoscope. 2008;118:1591-1596.
38.
KunstHLavieilleJPMarresH. Squamous cell carcinoma of the temporal bone: results and management. Otol Neurotol. 2008;29:549-552.
39.
LoboDLlorenteJLSuárezC. Squamous cell carcinoma of the external auditory canal. Skull Base. 2008;18:167-172.
CristalliGMancioccoVPichiB, et al. Treatment and outcome of advanced external auditory canal and middle ear squamous cell carcinoma. J Craniofac Surg. 2009;20:816-821.
42.
ItoMHatanoMYoshizakiT. Prognostic factors for squamous cell carcinoma of the temporal bone: extensive bone involvement or extensive soft tissue involvement?Acta Otolaryngol. 2009;129:1313-1319.
43.
RothschildSCiernikIFHartmannMSchuknechtBLütolfUMHuberAM. Cholesteatoma triggering squamous cell carcinoma: case report and literature review of a rare tumor. Am J Otolaryngol. 2009;30:256-260.
44.
LiuSCKangBHNiehSChangJLWangCH. Adenoid cystic carcinoma of the external auditory canal. J Chin Med Assoc. 2012;75:296-300.
45.
BacciuAClementeIAPiccirilloEFerrariSSannaM. Guidelines for treating temporal bone carcinoma based on long-term outcomes. Otol Neurotol. 2013;34:898-907.
46.
LassigAASpectorMESolimanSEl-KashlanHK. Squamous cell carcinoma involving the temporal bone: lateral temporal bone resection as primary intervention. Otol Neurotol. 2013;34:141-150.
47.
LeongSCYoussefALesserTH. Squamous cell carcinoma of the temporal bone: outcomes of radical surgery and postoperative radiotherapy. Laryngoscope. 2013;123:2442-2448.
48.
ShaoAWongDKMcIvorNP, et al. Parotid metastatic disease from cutaneous squamous cell carcinoma: prognostic role of facial nerve sacrifice, lateral temporal bone resection, immune status and P-stage. Head Neck. 2014;36:545-550.
49.
BeyeaJAMoberlyAC. Squamous cell carcinoma of the temporal bone. Otolaryngol Clin North Am. 2015;48:281-292.
50.
KhaimookWPlodpaiY. Malignant tumors of temporal bone in Songklanagarind Hospital: management and results. J Med Assoc Thailand. 2015;98:273-278.
51.
SasindranVJosephCPanickerSJohnM. Basosquamous cell carcinoma of pinna. Indian J Otol. 2015;21:290-293.
52.
ShinomiyaHHasegawaSYamashitaD, et al. Concomitant chemoradiotherapy for advanced squamous cell carcinoma of the temporal bone. Head Neck. 2016;38(suppl 1):E949-E953.
53.
GhavamiYHaidarYMMaducdocM, et al. Tympanic membrane and ossicular-sparing modified lateral temporal bone resection. Otolaryngol Head Neck Surg. 2017;157:530-532.
54.
MaxwellAKTakedaHGubbelsSP. Primary middle ear mucosal melanoma: case report and comprehensive literature review of 21 cases of primary middle ear and eustachian tube melanoma. Ann Otol Rhinol Laryngol. 2018;127:856-863.
55.
MuellemanTChowdhuryNIKilleenD, et al. Effect of piecemeal vs en bloc approaches to the lateral temporal bone on survival outcomes. Otolaryngol Head Neck Surg. 2018;158:716-720.
56.
LeeSKongSKBaeSHPakKOhSJ. Acellular dermal matrix mistaken as recurrence of malignancy following surgery on positron emission tomography/computed tomography: a case report. Ann Otol Rhinol Laryngol. 2019;128:1189-1193.
57.
ShinomiyaHUeharaNTeshimaMKakigiAOtsukiNNibuKI. Clinical management for T1 and T2 external auditory canal cancer. Auris Nasus Larynx. 2019;46:785-789.
58.
ChenSLHuangSFHoVWChuangWYChanKC. Clinical characteristics and treatment outcome of adenoid cystic carcinoma in the external auditory canal. Biomed J. 2020;43:189-194.
59.
XieBWangMZhangSLiuY. Parotidectomy in the management of squamous cell carcinoma of the external auditory canal. Eur Arch Otorhinolaryngol. 2021;278:1355-1364.
60.
AppelbaumENGrossNDDiabABishopAJNaderMEGidleyPW. Melanoma of the external auditory canal: a review of seven cases at a tertiary care referral center. Laryngoscope. 2021;131:165-172.
61.
LovinBDGidleyPW. Squamous cell carcinoma of the temporal bone: a current review. Laryngoscope Investig Otolaryngol. 2019;4:684-692.
62.
MorrisLGMehraSShahJPBilskyMHSelesnickSHKrausDH. Predictors of survival and recurrence after temporal bone resection for cancer. Head Neck. 2012;34:1231-1239.
63.
DeanNRWhiteHNCarterDS, et al. Outcomes following temporal bone resection. Laryngoscope. 2010;120:1516-1522.
64.
OyaRTakenakaYTakemuraK, et al. Surgery with or without postoperative radiation therapy for early-stage external auditory canal squamous cell carcinoma: a meta-analysis. Otol Neurotol. 2017;38:1333-1338.
65.
OgawaKNakamuraKHatanoK, et al. Treatment and prognosis of squamous cell carcinoma of the external auditory canal and middle ear: a multi-institutional retrospective review of 87 patients. Int J Radiat Oncol Biol Phys. 2007;68:1326-1334.
66.
MoritaSHommaANakamaruY, et al. The outcomes of surgery and chemoradiotherapy for temporal bone cancer. Otol Neurotol. 2016;37:1174-1182.
67.
WolfeSQTummalaRPMorcosJJ. Cerebral revascularization in skull base tumors. Skull Base. 2005;15(1):71-82.
68.
HigginsTSAntonioSA. The role of facial palsy in staging squamous cell carcinoma of the temporal bone and external auditory canal: a comparative survival analysis. Otol Neurotol. 2010;31:1473-1479.
69.
OmuraGAndoMSaitoY, et al. Survival impact of local extension sites in surgically treated patients with temporal bone squamous cell carcinoma. Int J Clin Oncol. 2017;22:431-437.
70.
RooperLMAgaimyADicksonBC, et al. DEK-AFF2 carcinoma of the sinonasal region and skull base: detailed clinicopathologic characterization of a distinctive entity. Am J Surg Pathol. 2021;45(12):1682-1693.
71.
TodorovicETruongTEskanderA, et al. Middle ear and temporal bone nonkeratinizing squamous cell carcinomas with DEK-AFF2 fusion: an emerging entity. Am J Surg Pathol. 2020;44:1244-1250.
72.
CramerJDBurtnessBFerrisRL. Immunotherapy for head and neck cancer: recent advances and future directions. Oral Oncol. 2019;99:104460.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
